Shares of LifeStance Health Group (LFST) have gained 13.7% over the past four weeks to close the last trading session at $5.58, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $8.64 indicates a potential upside of 54.8%. The mean estimate comprises seven short-term price targets with a standard deviation of $0.94. While the lowest estimate of $7 indicates a 25.5% increase from t ...

FOCUS combines a precision blend of citicoline, tyrosine and pure lion's mane mushroom to deliver superior TORONTO, July 26, 2024 (GLOBE NEWSWIRE) -- Lifeist Wellness Inc. ("Lifeist" or the "Company") (TSXV: LFST) (FRANKFURT: M5B) (OTCMKTS: LFSWF), a health-tech company that leverages advancements in science and technology to build breakthrough ventures that transform human wellness, is pleased to announce that its U.S. biosciences subsidiary Mikra Cellular Sciences Inc. ("Mikra") is on track building out a ...

LifeStance Health Group (LFST) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices. The power of a changing earnings picture in determining near-term stock price movements makes the Zacks rating system highly useful for individual investors, since it can be difficult to make decisions based on rating upgrades by Wall Street anal ...

TORONTO, July 19, 2024 (GLOBE NEWSWIRE) -- Lifeist Wellness Inc. ("Lifeist" or the "Company") (TSXV: LFST) (FRANKFURT: M5B0) (OTCMKTS: LFSWF) a health-tech company that leverages advancements in science and technology to build breakthrough ventures that transform human wellness, today announced that it has closed a non-brokered private placement (the "Offering") of secured convertible debentures (the "Debentures") for aggregate gross proceeds to the Company of $450,000 ("Principal Amount"). The Company inte ...

SCOTTSDALE, Ariz., July 18, 2024 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation's largest providers of outpatient mental health care, will issue its second quarter 2024 earnings release before the market opens on Thursday, August 8, 2024. LifeStance will host a live earnings conference call to discuss second quarter results on August 8, 2024, at 8:30 a.m. Eastern Time. To participate in the call, please dial 1-800-715-9871, domestically, or 1-646-307-1963, internationall ...

TORONTO, July 18, 2024 (GLOBE NEWSWIRE) -- Lifeist Wellness Inc. ("Lifeist" or the "Company") (TSXV: LFST) (FRANKFURT: M5B0) (OTCMKTS: LFSWF), a health-tech company that leverages advancements in science and technology to build breakthrough ventures that transform human wellness, reports that its U.S. biosciences subsidiary Mikra Cellular Sciences Inc. ("Mikra") has unveiled its Big Summer Sale, with a free gift included with every order while supplies last. The sale is on now, and customers are invited to ...

The mean estimate comprises seven short-term price targets with a standard deviation of $0.94. While the lowest estimate of $7 indicates a 27.5% increase from the current price level, the most optimistic analyst expects the stock to surge 82.2% to reach $10. It's very important to note the standard deviation here, as it helps understand the variability of the estimates. The smaller the standard deviation, the greater the agreement among analysts. However, an impressive consensus price target is not the only ...

CELLF 2.0 provides a complete adult daily dose of Pyrroloquinoline Quinone (PQQ) and Glutathione, alongside the recommended dose of bioavailable CoQ10, in a liposomal gel that is precision engineered to protect all of these key molecules from the corrosive effects of stomach acid, delivering them safely to be absorbed by the small intestine and guaranteeing that the full clinical dose becomes bioavailable. The latest published research confirms the vital role played by CELLF 2.0's key ingredients. In 2023 a ...

SSC is a leading Canadian cannabis company which has successfully implemented innovative systems and operational methodologies resulting in six straight quarters of positive EBITDA and positive net income in Q1 2024. Lifeist shareholders are set to immediately benefit by having SSC support the operations of CannMart, deploying SSC's expertise from its existing operations, while enjoying a fee structure which ensures a minimum net revenue amount to be retained by CannMart each month. This arrangement will al ...

We use Relative Strength Index (RSI), one of the most commonly used technical indicators, for spotting whether a stock is oversold. This is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. Usually, a stock is considered oversold when its RSI reading falls below 30. Technically, every stock oscillates between being overbought and oversold irrespective of the quality of their fundamentals. And the beauty of RSI is that it helps you quickly and e ...